Do you follow our Newsletter? Sign up here!
The latest news
Aqilion receives IND approval from the FDA. Read more.
OncoZenge has received confirmation that the NDRC has issued a certificate of approval for the investment agreement entered into between OncoZenge and on January 27, 2025. Read more.
Clinical validation study of Cinema hits GastroPanel rapid test conducted in India. Read more.
SynAct Pharma receives Issue Notification and Patent Term Adjustment for patent in the US regarding combination treatment with resomelagon (AP1189). Read more.
UsDsign has reached the milestone of 10 treated patients in the US with the nanosynthetic bone graft OssDsign Catalyst. Read more.
ProstaLund initiates strategic review due to weakened liquidity and takes out a loan of SEK 2,5 million. Read more.
Biovica collaborates with tense to expand the commercial reach of DiviTum TKa. Read more.
Herantis Pharma announces that the first patients dosed in the final cohort of the Phase Ib study in Parkinson's disease. Read more.
Hansa Biopharma appoints Maria Törnsén as Chief Operating Officer and President US Read more.
Magnasense announces the outcome of the rights issue of units. Read more.
ADDvise Group announces management changes. Read more.
Insider trading & whistleblowing
Arctic Bioscience Elekta Embla Medical Genmab
Invitations & presentations
Acarix Alligator Bioscience AstraZeneca BioArctic Cereno Scientific Nose Plugs Orthoma
Communiqués
AcuCort ADDvise Group BrainCool Iconovo
Summons
Arctic Bioscience UsDsign Isofol Medical Scandinavian Real Heart
Reports
Abera Bioscience Asker Healthcare Cantargia CombiGene Moberg Pharma Odinwell SciBase
The latest from BioStock
» Safe Life strengthens global presence with five acquisitions
» Biosergen strengthens the board with an expert in anti-infective drugs
» Trump wants to cut drug prices by up to 80 percent
» Age Labs on the collaboration with Lipum: "We want to enable precision medicine in RA"
» Zepbound outperforms Wegovy in new study
